Personalized Stem Cells - FDA Approved Clinical Trials
  • Home
  • Patient
    • FAQ
  • Physician
  • Clinical Trials
    • Knee Osteoarthritis (fully enrolled)
    • COVID-19 Clinical Trials
    • Future Clinical Trials
  • About
    • Personalized Stem Cells
    • Leadership
    • Investors
  • Media
    • News
    • Blog
    • Videos
    • Facebook
  • Contact
  • 833-772-3557
Select Page
Knee Osteoarthritis Clinical Trial Update: Data Collection Milestone

Knee Osteoarthritis Clinical Trial Update: Data Collection Milestone

Jan 22, 2021

2020 was a whirlwind of a year for most of us. Individuals, families, and businesses all over the world were affected by the global pandemic. Nobody expected the year’s crazy turn of events, and most of us found ourselves in uncharted territory when it came to...

read more
Stem Cell Therapy for Traumatic Brain Injury

Stem Cell Therapy for Traumatic Brain Injury

Jan 8, 2021

Stem cell therapy may be an effective treatment option for traumatic brain injury.

read more

Personalized Stem Cells’ Parent Company Celebrates 15 Years as Biocom Member

Dec 18, 2020

Our parent company, VetStem Biopharma, recently reached their 15 year anniversary as a member of Biocom, a life science association.

read more

Meet Dr. Robert Harman, Co-Founder and CEO of Personalized Stem Cells

Dec 4, 2020

Co-Founder and CEO of Personalized Stem Cells Inc., Dr. Robert Harman, has dedicated the majority of his career to developing stem cell therapy for humans and animals.

read more

Stem Cell Therapy for Pain Management

Nov 13, 2020

Recent literature supports the notion that stem cells have the ability to directly modulate pain.

read more

One Medicine: Animals Helping People

Oct 30, 2020

Nearly two decades’ worth of experience in the veterinary field led to the formation of Personalized Stem Cells, a human adipose-derived stem cell company.

read more

Personalized Stem Cells Out-Licenses Allogeneic Stem Cell Program Including COVID-19 Therapy

Oct 16, 2020

Personalized Stem Cells announces licensing agreement for its allogeneic stem cell program including COVID-19 therapy.

read more

Faith in Regenerative Medicine: Securing Funding During Uncertain Times

Oct 2, 2020

Personalized Stem Cells secured $2.5 million during a Series A round of financing in spite of the current economic crisis.

read more

Personalized Stem Cells Joins the Fight Against COVID-19

Sep 18, 2020

When COVID-19 was declared a global pandemic, we at Personalized Stem Cells felt called to action to manufacture and provide potentially life-saving stem cell therapy to patients ill with COVID-19.

read more

The Stem Cell Clinical Trial That Could: Overcoming COVID-19 Challenges

Sep 4, 2020

Personalized Stem Cells has completed enrollment of their first FDA approved stem cell clinical trial.

read more
« Older Entries
Copyright © 2021. Personalized Stem Cells. All rights reserved. Privacy Policy
/* First CSS File */ var giftofspeed = document.createElement('link'); giftofspeed.rel = 'stylesheet'; giftofspeed.href = 'https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css'; giftofspeed.type = 'text/css'; var godefer = document.getElementsByTagName('link')[0]; godefer.parentNode.insertBefore(giftofspeed, godefer);